Among the eight responders, only one primary tumour expressed Fas, and all five metastatic tumours available from responders were negative for Fas, including a metastatic tumour from a patient with positive Fas on the primary RCC (Table 2). This evidence concerns the gene FAS and renal cell adenocarcinoma.